• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Scientists Discover Genetic Variants Responsible for Mucinous Ovarian Cancer

Article

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.

Scientists at the Keck School of Medicine, University of Southern California, have identified 3 gene variants of HOXD9, which can help explain the development of the fourth most common cause of cancer in the United States, ovarian cancer.

"By finding these genetic markers, we begin to understand more about the biology of the disease itself," said Dr Simon Gayther, the corresponding author on the manuscript that was published in Nature Genetics, in a statement.

The retrospective study was conducted in 1644 women diagnosed with mucinous ovarian cancer and 21000 women without the disease, under the umbrella of the Collaborative Oncological Gene-environment Study, created to determine the risks of breast, ovarian, and prostate cancer.

Read more on ScienceDaily: http://bit.ly/1IiNBKp

Related Videos
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.